OKYO Bathi mangsa ngarep OKYO Pharma

Logo korporat perusahaan OKYO Pharma Limited (OKYO)

OKYO Pharma Limited is implementing robotic systems and bioinformatics to accelerate the discovery of molecules targeting ocular pathologies. The company's estimated profit reflects market expectations, where the mark captures the latest data. Efficient distribution of drops through pharmacy chains ensures access to therapy, while capitalization relies exclusively on the results of clinical trials for dry eye medications.

OKYO: Bathi resik sing dikarepake OKYO Pharma Limited 04.07.2022 - 18.11.2026

Rincian metrik lan analitis perusahaan OKYO Pharma Inc (OKYO)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:OKYO, OKYO Pharma Limited
Produk dadi OKYO Pharma Ltd

This metric measures the expected net return, adjusted for market volatility and operating expenses. It discounts future cash flows, allowing for an assessment of the business's fundamental value. The analytical earnings forecast visualizes the trend of these expectations, signaling a potential asset revaluation. For OKYO Pharma Limited (OKYO), this is critical: low synthesis costs for drops coupled with global demand create colossal scalability leverage.